Burning Rock Biotech Limited BNR


Sector:

Healthcare

Industry:

Medical - Diagnostics & Research

Description:

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and OncoScreen ParpMatch and OncoCompass ParpMatch to target critical genes associated with homologous recombination deficiency. In addition, the company has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China. It has collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. The company was incorporated in 2014 and is headquartered in Guangzhou, China.

Recent Quarter:

2024-12-03

Upcoming Quarter:

N/A

Annual Reports

Date2024-04-29
Revenue 537,435,000
Net Income -653,689,000
EPS -63.84
Basic Shares 10,239,654
Diluted Shares 10,239,654
Report Link
Date2023-04-20
Revenue 563,238,000
Net Income -971,233,000
EPS -9.35
Basic Shares 103,908,948
Diluted Shares 103,908,948
Report Link
Date2022-04-29
Revenue 507,862,000
Net Income -796,697,000
EPS -7.65
Basic Shares 104,207,859
Diluted Shares 104,207,859
Report Link
Date2021-03-23
Revenue 429,903,000
Net Income -373,706,000
EPS -5.44
Basic Shares 68,634,479
Diluted Shares 68,634,479
Report Link
Date2019-12-31
Revenue 381,677,000
Net Income -168,337,000
EPS -1.94
Basic Shares 86,819,626
Diluted Shares 86,819,626
Report Link
Date2018-12-31
Revenue 208,867,000
Net Income -177,497,000
EPS -7.93
Basic Shares 22,378,876
Diluted Shares 22,384,008
Report Link
Date2017-12-31
Revenue 111,166,000
Net Income -131,275,000
EPS -1.6
Basic Shares 82,077,544
Diluted Shares 82,077,544
Report Link

Annual Ratios

Date2023-12-31
PE -1.03
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -16.60
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -79.18
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -276.82
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -884.34
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -213.51
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-12-31
PE -1001.92
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-12-04
Revenue 128,644,000
Net Income -35,745,000
EPS -3.46
Basic Shares 10,322,752
Diluted Shares 10,322,752
Report Link
Date2024-08-23
Revenue 135,533,000
Net Income -108,038,000
EPS -10.53
Basic Shares 10,260,000
Diluted Shares 10,260,000
Report Link
Date2024-03-28
Revenue 125,623,000
Net Income -121,549,000
EPS -11.85
Basic Shares 10,254,404
Diluted Shares 10,254,404
Report Link
Date2023-11-30
Revenue 121,085,000
Net Income -162,213,000
EPS -1.58
Basic Shares 102,396,208
Diluted Shares 102,396,208
Report Link
Date2023-09-05
Revenue 127,566,000
Net Income -174,981,000
EPS -1.71
Basic Shares 102,325,717
Diluted Shares 102,325,717
Report Link
Date2023-05-30
Revenue 146,268,000
Net Income -131,242,000
EPS -1.28
Basic Shares 102,475,900
Diluted Shares 102,475,900
Report Link
Date2023-03-28
Revenue 142,516,000
Net Income -185,253,000
EPS -1.81
Basic Shares 102,390,433
Diluted Shares 102,390,433
Report Link
Date2022-11-16
Revenue 142,237,000
Net Income -216,225,000
EPS -2.11
Basic Shares 102,376,730
Diluted Shares 102,376,730
Report Link
Date2022-08-31
Revenue 154,631,000
Net Income -226,309,000
EPS -2.18
Basic Shares 103,910,170
Diluted Shares 103,910,170
Report Link
Date2022-05-31
Revenue 130,846,000
Net Income -262,137,000
EPS -2.5
Basic Shares 104,857,387
Diluted Shares 104,857,387
Report Link
Date2022-03-22
Revenue 135,524,000
Net Income -257,965,000
EPS -2.47
Basic Shares 104,504,600
Diluted Shares 104,504,600
Report Link
Date2021-11-16
Revenue 147,345,000
Net Income -251,144,000
EPS -2.4
Basic Shares 104,453,145
Diluted Shares 104,453,145
Report Link
Date2021-08-31
Revenue 126,615,000
Net Income -170,477,000
EPS -1.64
Basic Shares 104,233,823
Diluted Shares 104,233,823
Report Link
Date2021-05-25
Revenue 127,279,000
Net Income -203,665,000
EPS -1.96
Basic Shares 104,089,108
Diluted Shares 104,089,108
Report Link
Date2021-03-11
Revenue 106,623,000
Net Income -171,411,000
EPS -1.65
Basic Shares 104,046,111
Diluted Shares 104,046,111
Report Link
Date2020-11-20
Revenue 131,722,000
Net Income -156,478,000
EPS -1.51
Basic Shares 103,836,647
Diluted Shares 103,836,647
Report Link
Date2020-08-11
Revenue 123,881,000
Net Income -127,130,000
EPS -1.22
Basic Shares 103,804,534
Diluted Shares 103,804,534
Report Link
Date2020-08-11
Revenue 106,971,000
Net Income -71,055,000
EPS -1.74
Basic Shares 40,786,167
Diluted Shares 40,786,167
Report Link
Date2020-03-31
Revenue 67,329,000
Net Income -52,572,000
EPS -0.52
Basic Shares 101,988,521
Diluted Shares 101,988,521
Report Link
Date2019-12-31
Revenue 88,675,000
Net Income -95,094,000
EPS -1.1
Basic Shares 86,819,626
Diluted Shares 86,819,626
Report Link
Date2019-09-30
Revenue 103,724,000
Net Income -32,167,000
EPS -0.37
Basic Shares 86,819,626
Diluted Shares 86,819,626
Report Link
Date2019-06-30
Revenue 84,813,000
Net Income -26,030,000
EPS -0.3
Basic Shares 86,819,626
Diluted Shares 86,819,626
Report Link
Date2019-03-31
Revenue 104,465,000
Net Income -15,865,000
EPS -0.18
Basic Shares 86,819,626
Diluted Shares 86,819,626
Report Link
Date2018-12-31
Revenue 65,274,000
Net Income -68,121,000
EPS -29.42
Basic Shares 2,315,519
Diluted Shares 2,315,519
Report Link

Quarterly Ratios

Date2024-09-30
PE -1.66
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-06-30
PE -1.08
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -1.07
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -10.42
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE -10.35
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -30.43
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -26.66
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -18.37
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE -19.52
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -19.50
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -59.67
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -62.94
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -176.19
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -243.03
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -267.68
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -250.05
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-09-30
PE -347.66
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE -273.84
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE -846.02
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -391.37
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-09-30
PE -1187.88
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-06-30
PE -1406.66
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-03-31
PE -2261.49
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -14.39
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

66.89

Price:

$6.94

Market Cap:

67,745,199

EPS TTM:

-27.42

PE Ratio:

-1.22

PEPSG:

NaN

Fwd PE:

NaN

Volume:

34,438

2 Year Price Change

0.246

Index 2 Year Price Change

1.509

5 Year Price Change

No Price 5 Years Ago

Index 5 Year Price Change

1.912

PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: